A KHN database shows that $58 million flowed from drugmakers to patient groups running national ads.
The Food and Drug Administration is supposed to inspect all factories, foreign and domestic, that produce drugs for the U.S. market. But a KHN review of thousands of FDA documents — inspection records, recalls, warning letters and lawsuits — reveals how drugs that are poorly manufactured or contaminated can reach consumers.
Drugmakers’ contributions to lawmakers have peaked as surging drug prices emerge as a hot-button political issue. In the past decade, Congress has received nearly $79 million from 68 pharma PACs, run by employees of companies that make drugs treating everything from cancer to erectile dysfunction.
As the number of Americans with dementia rises, health professionals grapple with how to talk to patients about gun safety at home.
A decade ago, California stopped licensing surgery centers and then gave approval power to private accreditors that are commonly paid by the same centers they inspect. That system of oversight has created a troubling legacy of laxity, a Kaiser Health News investigation finds.
As HHS decided to cut $1.6 billion in drug payments to hospitals, it weighed thousands of comments generated by a pharmaceutical-funded advocacy group.
No one tracks sepsis cases closely enough to know how often these severe infections turn fatal. But the toll — both human and financial — is enormous, finds an investigation by KHN and the Chicago Tribune.
Shepherd Smith, a strong supporter of abstinence-only sex education for AIDS, has been close to the new director of the CDC for decades. This connection is just one example of the “new in crowd” surrounding the Trump administration, where politics and religion mix.
The doctor most responsible for turning the sunshine supplement into a billion-dollar juggernaut has received hundreds of thousands of dollars from the vitamin D industry, according to government records and interviews.
A Kaiser Health News and USA Today Network investigation finds that a hodgepodge of state rules governing outpatient centers allow some deaths and serious injuries to go unexamined. And no rule stops a doctor exiled by a hospital for misconduct from opening a surgery center down the street.
As more Americans are diagnosed with dementia, families who have firearms struggle with ways to stay safe. A KHN investigation uncovered dozens of cases of deaths and injuries.
An inside look at how Purdue Pharma pushed OxyContin despite risks of addiction and fatalities.
The Food and Drug Administration rarely prosecutes research violations, but its criminal division is looking into the experimental herpes vaccine research by Southern Illinois University professor William Halford.
Kaiser Health News launches “Pre$cription for Power,” a groundbreaking database to expose Big Pharma’s ties to patient groups.
Three participants in unauthorized herpes vaccine research file a lawsuit against scientist’s company, alleging adverse side effects.
An investigation by Kaiser Health News and the USA TODAY Network discovers that more than 260 patients have died since 2013 after in-and-out procedures at surgery centers across the country. More than a dozen — some as young as 2 — have perished after routine operations, such as colonoscopies and tonsillectomies.
Have you gotten a medical bill that sounds way too expensive or is just downright confusing? Send it to us. KHN Editor-in-Chief Elisabeth Rosenthal talks with NPR Morning Edition Host Steve Inskeep about the launch of “Bill Of The Month,” KHN and NPR’s new crowdsourced investigation.
Kaiser Health News, in collaboration with NPR, kicks off a series that will examine and decode your perplexing medical bills.
Elizabeth Moreno got hit with a $17,850 bill from a Texas lab after leaving a urine sample at her doctor’s office.
A KHN data analysis finds that the door of opportunities connecting Capitol Hill, the federal government and the drug industry likely spins in Big Pharma’s favor.